Literature DB >> 23436177

Cure of relapsing nephrosis by an allogeneic marrow graft for chronic myelogenous leukemia.

Keisuke Sugimoto1, Naoki Sakata, Shinsuke Fujita, Tomoki Miyazawa, Hitomi Nishi, Tsukasa Takemura, Mitsuru Okada.   

Abstract

BACKGROUND: Minimal-change nephrotic syndrome has recently been attributed to an immature, dysfunctional T-cell population. CASE-DIAGNOSIS/TREATMENT: A woman, now 23 years old, developed nephrotic syndrome when she was 6 years old. Despite treatment with steroids and immunosuppressants such as cyclosporine, mizoribine, mycophenolate mofetil, and tacrolimus, the patient relapsed 14 times. At the age of 19 years, she developed chronic myelogenous leukemia, against which imatinib achieved cytogenetic remission. The patient received an allogeneic bone marrow graft transplantation from an unrelated marrow bank donor, with an uncomplicated recovery and molecular genetic remission. Immunosuppressants were withdrawn within 6 months. The patient is now without drug treatment. Complete remission of nephrotic syndrome has also been maintained for over 4 years without any drug administration.
CONCLUSIONS: The patient's course supports suggestions that immunological dysfunction in nephrosis is associated with abnormality of immature, relatively unclassified T cells (CD34(+)) representing hematopoietic stem cells, as opposed to mature T cells (CD34(-)).

Entities:  

Mesh:

Year:  2013        PMID: 23436177     DOI: 10.1007/s00467-013-2433-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  15 in total

1.  Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome.

Authors:  K Tenbrock; A Schubert; L Stapenhorst; M J Kemper; J Gellermann; K Timmermann; D E Müller-Wiefel; U Querfeld; B Hoppe; D Michalk
Journal:  Clin Sci (Lond)       Date:  2002-05       Impact factor: 6.124

2.  T-cell transcriptome analysis points up a thymic disorder in idiopathic nephrotic syndrome.

Authors:  Hicham Mansour; Lydie Cheval; Jean-Marc Elalouf; Jean-Christophe Aude; Maria-Alexandra Alyanakian; Béatrice Mougenot; Alain Doucet; Georges Deschênes
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

3.  Membranoproliferative glomerulonephritis secondary to chronic myeloid leukemia.

Authors:  Murali Subramanian; Nalini Kilara; R Manjunath; Vijaya Mysorekar
Journal:  Saudi J Kidney Dis Transpl       Date:  2010-07

4.  A long-term remission of renal amyloidosis with nephrotic syndrome after autologous peripheral blood stem-cell transplantation.

Authors:  Kazuei Ogawa; Kazuhiko Ikeda; Miki Furukawa; Kayo Harada-Shirado; Yumiko Mashimo; Hiroshi Takahashi; Hayato Matsumoto; Satoshi Kimura; Akiko Shichishima-Nakamura; Hiroshi Ohkawara; Yuko Hashimoto; Koichi Asahi; Hideyoshi Noji; Hitoshi Ohto; Yasuchika Takeishi
Journal:  Fukushima J Med Sci       Date:  2010-12

Review 5.  Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: report of 21 cases and review of the literature.

Authors:  V Audard; F Larousserie; P Grimbert; M Abtahi; J-J Sotto; A Delmer; F Boue; D Nochy; N Brousse; R Delarue; P Remy; P Ronco; D Sahali; P Lang; O Hermine
Journal:  Kidney Int       Date:  2006-05-03       Impact factor: 10.612

Review 6.  [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].

Authors:  Z Adam; M Krejcí; L Pour; S Stepánková; Z Cermáková; L Voska; V Teplan; A Krivanová; R Hájek; J Mayer
Journal:  Vnitr Lek       Date:  2009-11

7.  Long term complete remission of severe nephrotic syndrome secondary to diffuse global (IV-G) lupus nephritis following autologous, haematopoietic peripheral stem (CD34+) cell transplantation.

Authors:  A M Marmont; F Gualandi; M T van Lint; C Guastoni; A Bacigalupo
Journal:  Lupus       Date:  2006       Impact factor: 2.911

8.  A humanized mouse model of idiopathic nephrotic syndrome suggests a pathogenic role for immature cells.

Authors:  Anne-Laure Sellier-Leclerc; Arnaud Duval; Stéphanie Riveron; Marie-Alice Macher; Georges Deschenes; Chantal Loirat; Marie-Christine Verpont; Michel Peuchmaur; Pierre Ronco; Renato C Monteiro; Elie Haddad
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

Review 9.  Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome.

Authors:  José G van den Berg; Jan J Weening
Journal:  Clin Sci (Lond)       Date:  2004-08       Impact factor: 6.124

10.  Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation.

Authors:  Sarah Bruneau; Ludmilla Le Berre; Caroline Hervé; Asta Valanciuté; Maud Kamal; Jeanne Naulet; Laurent Tesson; Yohann Foucher; Jean-Paul Soulillou; Djillali Sahali; Jacques Dantal
Journal:  Am J Kidney Dis       Date:  2009-06-10       Impact factor: 8.860

View more
  3 in total

1.  Long-term remission of HSCT-related NS after a second allogenic stem cell transplant.

Authors:  Shogo Kobayashi; Yukihiko Kawasaki; Hideki Sano; Kazuhiro Mochizuki; Mitsuaki Hosoya; Atsushi Kikuta
Journal:  Pediatr Nephrol       Date:  2015-12-11       Impact factor: 3.714

2.  Markers of disease and steroid responsiveness in paediatric idiopathic nephrotic syndrome: Whole-transcriptome sequencing of peripheral blood mononuclear cells.

Authors:  Hee Gyung Kang; Heewon Seo; Jae Hyun Lim; Jong Il Kim; Kyoung Hee Han; Hye Won Park; Ja Wook Koo; Kee Hyuck Kim; Ju Han Kim; Hae Il Cheong; Il-Soo Ha
Journal:  J Int Med Res       Date:  2017-01-01       Impact factor: 1.671

3.  The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis.

Authors:  Jie Chen; Hua Liu; Wenjun Yin; Zhengguang Xu; Zekai Chen; Wingkeung Yiu
Journal:  Comput Intell Neurosci       Date:  2022-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.